Patents by Inventor Evan Phillip McMenamy

Evan Phillip McMenamy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200371029
    Abstract: A quantitative method for diagnosing an autoimmune disease or an infectious disease comprising performing an automated diagnostic assay, comprising: incubating a capture reagent with a streptavidin-coated medium to form a solid phase complex, wherein the capture reagent is a biotinylated autoantigen or infectious disease antigen; washing the solid phase complex to remove excess capture reagent; incubating the solid phase complex with a serum sample to form an immune complex; washing the immune complex to remove any unbound sample; incubating the immune complex with a conjugate to create an immune-conjugate complex; washing the immune-conjugate complex to remove any unbound conjugate; introducing a substrate capable of generating a quantifiable response; and calibrating the response generated from introducing the substrate.
    Type: Application
    Filed: July 28, 2020
    Publication date: November 26, 2020
    Inventors: Mark David Van Cleve, Taylor Addison Reid, Linda Marie Trondle, Victoria Hung, Yi Luo, Dennis Edwin Rieger, Evan Phillip McMenamy, Nanditha Raghavan, Morkoah Blay Reliford, Douglas John Canfield, Elaine Grace Taine, Edsel Lawrence Noche Sinson, Scott William Vande Wetering, Teri Taylor, Travis Knox, Fran Zulo Cuaresma Jacaine, James Weston, Jennifer Bao-Guey Chan, Stephanie TuVi Ortega, Rachel Sarah Schell, Ronald Norman Diamond, Steven Michael Gann, Eric Darnell Hall, Tae Ho Hwang, John Lewis Morton, Anatoly Moskalev, Marinela Gombosev Stack, Bruce Alan Sargeant, Michelle Fredrika Forshager, Vanessa Camille Chua, Kylie Wilson
  • Patent number: 10732111
    Abstract: A quantitative method for performing an automated diagnostic assay, comprising: incubating a capture reagent with a streptavidin-coated medium to form a solid phase complex; washing the solid phase complex to remove excess capture reagent; incubating the solid phase complex with a serum sample to form an immune complex; washing the immune complex to remove any unbound sample; incubating the immune complex with a conjugate to create an immune-conjugate complex; washing the immune-conjugate complex to remove any unbound conjugate; introducing a substrate capable of generating a quantifiable response; and calibrating the response generated from introducing the substrate.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: August 4, 2020
    Assignee: HYCOR Biomedical, LLC
    Inventors: Mark David Van Cleve, Taylor Addison Reid, Linda Marie Trondle, Victoria Hung, Yi Luo, Dennis Edwin Rieger, Evan Phillip McMenamy, Nanditha Raghavan, Morkoah Blay Reliford, Douglas John Canfield, Elaine Grace Taine, Edsel Lawrence Noche Sinson, Scott William Vande Wetering, Teri Taylor, Travis Knox, Fran Zylo Cuaresma Jacalne, James Weston, Jennifer Bao-Guey Chan, Stephanie TuVi Ortega, Rachel Sarah Schell, Ronald Norman Diamond, Steve Michael Gann, Eric Darnell Hall, Tae Ho Hwang, John Lewis Morton, Anatoly Moskalev, Marinela Gombosev Stack, Bruce Alan Sargeant, Michelle Fredrika Forshager, Vanessa Camille Chua, Kylie Wilson
  • Publication number: 20170212111
    Abstract: A quantitative method for performing an automated diagnostic assay, comprising: incubating a capture reagent with a streptavidin-coated medium to form a solid phase complex; washing the solid phase complex to remove excess capture reagent; incubating the solid phase complex with a serum sample to form an immune complex; washing the immune complex to remove any unbound sample; incubating the immune complex with a conjugate to create an immune-conjugate complex; washing the immune-conjugate complex to remove any unbound conjugate; introducing a substrate capable of generating a quantifiable response; and calibrating the response generated from introducing the substrate.
    Type: Application
    Filed: April 7, 2017
    Publication date: July 27, 2017
    Inventors: Mark David Van Cleve, Taylor Addison Reid, Linda Marie Trondle, Victoria Hung, Yi Luo, Dennis Edwin Rieger, Evan Phillip McMenamy, Nanditha Raghavan, Morkoah Blay Reliford, Douglas John Canfield, Elaine Grace Taine, Edsel Lawrence Noche Sinson, Scott William Vande Wetering, Teri Taylor, Travis Knox, Fran Zylo Cuaresma Jacalne, James Weston, Jennifer Bao-Guey Chan, Stephanie TuVi Ortega, Rachel Sarah Schell, Ronald Norman Diamond, Steve Michael Gann, Eric Darnell Hall, Tae Ho Hwang, John Lewis Morton, Anatoly Moskalev, Marinela Gombosev Stack, Bruce Alan Sargeant, Michelle Fredrika Forshager, Vanessa Camille Chua, Kylie Wilson
  • Patent number: 9658225
    Abstract: A quantitative method for performing an automated diagnostic assay, comprising: incubating a capture reagent with a streptavidin-coated medium to form a solid phase complex; washing the solid phase complex to remove excess capture reagent; incubating the solid phase complex with a serum sample to form an immune complex; washing the immune complex to remove any unbound sample; incubating the immune complex with a conjugate to create an immune-conjugate complex; washing the immune-conjugate complex to remove any unbound conjugate; introducing a substrate capable of generating a quantifiable response; and calibrating the response generated from introducing the substrate.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: May 23, 2017
    Assignee: Hycor Biomedical, LLC
    Inventors: Mark David Van Cleve, Taylor Addison Reid, Linda Marie Trondle, Victoria Hung, Yi Luo, Dennis Edwin Rieger, Evan Phillip McMenamy, Nanditha Raghavan, Morkoah Blay Reliford, Douglas John Canfield, Elaine Grace Taine, Edsel Lawrence Noche Sinson, Scott William Vande Wetering, Teri Taylor, Travis Knox, Fran Zylo Cuaresma Jacalne, James Weston, Jennifer Bao-Guey Chan, Stephanie TuVi Ortega, Rachel Sarah Schell, Ronald Norman Diamond, Steve Michael Gann, Eric Darnell Hall, Tae Ho Hwang, John Lewis Morton, Anatoly Moskalev, Marinela Gombosev Stack, Bruce Alan Sargeant, Michelle Fredrika Forshager, Vanessa Camille Chua, Kylie Wilson
  • Publication number: 20140274784
    Abstract: A quantitative method for performing an automated diagnostic assay, comprising: incubating a capture reagent with a streptavidin-coated medium to form a solid phase complex; washing the solid phase complex to remove excess capture reagent; incubating the solid phase complex with a serum sample to form an immune complex; washing the immune complex to remove any unbound sample; incubating the immune complex with a conjugate to create an immune-conjugate complex; washing the immune-conjugate complex to remove any unbound conjugate; introducing a substrate capable of generating a quantifiable response; and calibrating the response generated from introducing the substrate.
    Type: Application
    Filed: March 17, 2014
    Publication date: September 18, 2014
    Inventors: Mark David Van Cleve, Taylor Addison Reid, Linda Marie Trondle, Victoria Hung, Yi Luo, Dennis Edwin Rieger, Evan Phillip McMenamy, Nanditha Raghavan, Morkoah Blay Reliford, Douglas John Canfield, Yiling Nie, Edsel Lawrence Noche Sinson, Scott William Vande Wetering, Teri Taylor, Travis Knox, Fran Zylo Cuaresma Jacalne, James Weston, Jennifer Bao-Guey Chan, Stephanie TuViVo, Rachel Sarah Schell, Ronald Norman Diamond, Steve Michael Gann, Eric Darnell Hall, Tae Ho Hwang, John Lewis Morton, Anatoly Moskalev, Marinela Gombosev Stack, Bruce Alan Sargeant